ELVERA
Swedish Orphan Biovitrum AB (publ)
Application Filed: 2017-12-21
Trademark Application Details
APPROVED FOR PUBLICATION
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79227985 |
| Registration Number | 5736037 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Domestic Representative | Donna J. Bunton |
| Attorney Name | Donna J. Bunton |
| Attorney Docket Number | DJB/2739-148 |
| Law Office Assigned | N30 |
| Employee Name | MAZZELLA, BRANDY BARRE |
Timeline
| 2017-12-21 | Application Filed |
| 2019-01-04 | Location: TMO LAW OFFICE 121 - EXAMINING ATTORNEY ASSIGNED |
| 2019-01-04 | Status: Live/Pending |
| 2019-01-04 | Transaction Date |
| 2019-02-12 | Published for Opposition |
| 2019-04-30 | Trademark Registered |
Trademark Applicants & Owners
| Owner: |  Swedish Orphan Biovitrum AB (publ) |
| Address | SE-112 76 Stockholm SE |
| Legal Entity Type | Joint Stock Company |
| Legal Entity State | SE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0421 | Research and development of pharmaceuticals, protein pharmaceuticals, biological pharmaceuticals, proteins, protein structures, chemical modification of substances, compounds for efficient effect of drugs, compounds for controlled release of pharmaceutical substances within the pharmaceutical field; none of the aforementioned being cosmetic research |
| GS0051 | Medical and pharmaceutical preparations in the field of human medicine for the prevention and treatment of diseases and conditions in the therapeutic areas of hematology, inflammation, genetics and metabolism; medical drugs for human use for the treatment of diseases and conditions in the therapeutic areas of hematology, inflammation, genetics and metabolism; dietetic and nutritional preparations and substances in the form of foods and beverages adapted for medical use; protein pharmaceuticals in the field of human medicine for the prevention and treatment of diseases and conditions in the therapeutic areas of hematology, inflammation, genetics and metabolism; modified chemical compounds for medical purposes, namely, for the treatment of diseases and conditions in the therapeutic areas of hematology, inflammation, genetics and metabolism; modified protein arrays for medical use in the therapeutic areas of hematology, inflammation, genetics and metabolism; none of the aforementioned goods being cosmetic skin care preparations and cosmetics |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2018-03-01 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-03-06 | 2 NWOS I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2018-03-10 | 3 MAFR O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2018-04-02 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2018-04-02 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2018-04-03 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2018-04-09 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2018-04-09 | 8 RFCS P: |
| REFUSAL PROCESSED BY IB | 2018-04-27 | 9 RFNT P: |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2018-10-01 | 10 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2018-10-01 | 11 ARAA I:Incoming Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2018-10-09 | 12 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2018-10-09 | 13 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2018-10-10 | 14 TEME I:Incoming Correspondence |
| LIMITATION OF GOODS RECEIVED FROM IB | 2018-12-28 | 15 LIMG M: |
| LIMITATION FROM THE IB - REQUEST EXAM REVIEW | 2019-01-03 | 16 LIME X:Correction |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-01-04 | 17 CNSA O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-01-23 | 18 NONP E:E-Mail |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2019-01-23 | 19 OP2R P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2019-01-23 | 20 OPNS P: |
| NOTIFICATION PROCESSED BY IB | 2019-02-08 | 21 GPNX P: |
| PUBLISHED FOR OPPOSITION | 2019-02-12 | 22 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-02-12 | 23 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2019-04-30 | 24 R.PR A:Allowance for Publication |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2019-07-30 | 25 FICR P: |
| FINAL DISPOSITION PROCESSED | 2019-08-15 | 26 FIMP P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2019-08-16 | 27 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2019-09-06 | 28 FINO P: |
| NEW REPRESENTATIVE AT IB RECEIVED | 2019-12-20 | 29 NREP P: |
| LIMITATION OF GOODS RECEIVED FROM IB | 2020-11-20 | 30 LIMG M: |
| LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | 2021-03-16 | 31 LIMN I:Incoming Correspondence |
| COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | 2024-04-30 | 32 REM3 E:E-Mail |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 